Acerca de
the prize
The Maximon Longevity Prize for Translational Research awards outstanding breakthrough research in the field of longevity that can be translated for clinical or non-clinical applications and has the potential to substantially increase health span or life span of humans.
The award focuses on research that already has a proof of concept in pre-clinical lab studies to have a significant impact on the health optimization or longevity.
the pledge
Maximon is on a mission to extend the health span and to allow people to be fit, healthy and happy until high-age.
We are accelerating longevity research by giving exceptional researchers the resources they need to expand their work and invest in new products and services geared to a longevity-society.
Maximon pledges 50 000 CHF for the winner and commits to attracting more donors and sponsors to further improve the award.
The prize recipient will also receive additional benefits from sponsors such as:
-
Personalized longevity program sponsored by Biolytica at the value of 20 000 CHF
-
One-year subscription for science-based longevity supplements supplied by AVEA at the value of 5 000 CHF
jury
Dr. Dr. Elisabeth Roider
Partner & Chief Scientific and Medical Officer at Maximon
Sebastien Thuault
Chief Editor of Nature Aging
James Raaff
Co-Founder and Chief Program Officer at Biolytica
Prof. Brian Kennedy
Professor Departments of Biochemistry and Physiology at National University of Singapore
Prof. Dr. Evelyne Yehudit Bischof, MD, MPH
Associate Professor at Shanghai University of Medicine&Health Sciences
Sophie Chabloz
Co-Founder and CPO at AVEA
Prof. Dr. Collin Y. Ewald
Assistant Professor at ETH Zurich
Prof. Joao Pedro de Magalhaes
Professor, University of Liverpool
timeline
1st of March
2022
10th of September
2022
29th of September
2022
25th of September
2022
Longevity prize launch.
Applications are open
Application window is closed
End of Evaluation
phase
Award Ceremony at the LIC Gala Dinner
application
We've welcomed applications from all academic/non-profit researchers, inventors, scientists, students or startup founders who either published breakthrough research, hold the patent or are in very advanced stages of research.
Application window has closed on September 10th.
sponsors
partners
_edited.png){kind=logo}
team
Dr. Tobias Reichmuth
Founding Partner
Dr. Dr. Elisabeth Roider
Partner & Chief Scientific and Medical Officer
Alexandra Ezhkova
Venture Head of Events